Amir Inamdar

Dr. Amir Inamdar is a pharmaceutical physician based in the United Kingdom and serves as the chief medical officer at Cybin, a biotechnology company focused on psychedelic therapeutics. He has expertise in the development and application of novel treatment methodologies, particularly involving psychedelics. Inamdar has provided insights into the implications of recent research, noting the surprising improvements in motor symptoms among Parkinson's patients treated with psilocybin, while also emphasizing the need for further investigation into the mechanisms at play and the importance of rigorous clinical trials.